Issue 22, 2014

Rituximab–Au nanoprobes for simultaneous dark-field imaging and DAB staining of CD20 over-expressed on Raji cells

Abstract

A novel dual-modal cell immunodetection method based on both dark-field imaging and catalysis functions of gold nanoparticles has been established, where the Rituximab–Au conjugates were used as nanoprobes to label and image specifically the CD20 overexpressed on the surface of malignant lymphoma cells of Raji with high affinity.

Graphical abstract: Rituximab–Au nanoprobes for simultaneous dark-field imaging and DAB staining of CD20 over-expressed on Raji cells

Supplementary files

Article information

Article type
Communication
Submitted
23 Jul 2014
Accepted
11 Sep 2014
First published
11 Sep 2014

Analyst, 2014,139, 5660-5663

Author version available

Rituximab–Au nanoprobes for simultaneous dark-field imaging and DAB staining of CD20 over-expressed on Raji cells

L. Fan, D. Lou, Y. Zhang and N. Gu, Analyst, 2014, 139, 5660 DOI: 10.1039/C4AN01342E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements